Symbols / ISRG Stock $407.29 +1.24% Intuitive Surgical, Inc.

Healthcare • Medical Instruments & Supplies • United States • NMS
ISRG (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Medical Instruments & Supplies
CEO Mr. David J. Rosa
Exch · Country NMS · United States
Market Cap 144.25B
Enterprise Value 138.09B
Income 2.98B
Sales 10.58B
FCF (ttm) 2.25B
Book/sh 49.31
Cash/sh 12.76
Employees 17,021
Insider 10d —
IPO Jun 16, 2000
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E 49.37
Forward P/E 34.54
PEG 2.23
P/S 13.63
P/B 8.26
P/C —
EV/EBITDA 35.54
EV/Sales 13.05
Quick Ratio 3.26
Current Ratio 4.61
Debt/Eq —
LT Debt/Eq —
EPS (ttm) 8.25
EPS next Y 11.79
EPS Growth 18.80%
Revenue Growth 23.00%
EPS Gr Q/Q 17.60%
Rev Gr Q/Q —
Earnings (next) 2026-07-21
Earnings (prior) 2026-04-21
ROA 10.24%
ROE 17.23%
ROIC —
Gross Margin 66.29%
Oper. Margin 30.87%
Profit Margin 28.15%
Shs Outstand 354.16M
Shs Float 352.10M
Insider Own 0.55%
Instit Own 89.19%
Short Float 1.90%
Short Ratio 2.77
Short Interest 6.71M
52W High 603.88
vs 52W High -32.55%
52W Low 396.68
vs 52W Low 2.67%
Beta 1.51
Impl. Vol. 43.81%
Rel Volume 1.25
Avg Volume 2.10M
Volume 2.63M
Target (mean) $567.80
Tgt Median $574.00
Tgt Low $378.00
Tgt High $750.00
# Analysts 29
Recom Buy
Prev Close $402.30
Price $407.29
Change 1.24%
About

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. It offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung. The company also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of customer service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. It sells its products through direct sales organizations, such as capital and clinical sales teams. Intuitive Surgical, Inc. was incorporated in 1995 and is headquartered in Sunnyvale, California.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$567.80
Mean price target
2. Current target
$407.29
Latest analyst target
3. DCF / Fair value
$114.56
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$407.29
Low
$378.00
High
$750.00
Mean
$567.80

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-05-18 main B of A Securities Buy → Buy $520
2026-04-23 main Barclays Overweight → Overweight $651
2026-04-22 main Leerink Partners Outperform → Outperform $573
2026-04-22 main Baird Outperform → Outperform $610
2026-04-22 main Piper Sandler Overweight → Overweight $580
2026-04-22 reit BTIG Buy → Buy $574
2026-04-15 main Truist Securities Buy → Buy $580
2026-04-13 main Mizuho Neutral → Neutral $525
2026-04-10 reit BTIG Buy → Buy $616
2026-04-09 main Goldman Sachs Buy → Buy $609
2026-04-06 main Evercore ISI Group In-Line → In-Line $480
2026-03-17 main UBS Neutral → Neutral $550
2026-03-11 up Citigroup Neutral → Buy $590
2026-02-24 main UBS Neutral → Neutral $570
2026-01-27 up Freedom Capital Markets Hold → Buy $610
2026-01-27 init TD Cowen — → Buy $660
2026-01-26 main Barclays Overweight → Overweight $712
2026-01-26 up Freedom Broker Hold → Buy $610
2026-01-23 main Citigroup Neutral → Neutral $590
2026-01-23 main Evercore ISI Group In-Line → In-Line $550
News
RSS: Latest ISRG news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-05-22 BROSIUS MARK PRESTON Officer — 36 $439.80 $15,945
2026-05-20 BROSIUS MARK PRESTON Officer — 54 $422.47 $23,464
2026-05-11 LOEB GARY Officer — 400 $446.95 $178,780
2026-04-30 LADD AMY L Director — 531 — —
2026-04-30 REED MONICA P Director — 531 — —
2026-04-30 KOLLI SREELAKSHMI Director — 531 — —
2026-04-30 CHEW LEWIS Director — 531 — —
2026-04-30 BARRATT CRAIG H Director — 750 — —
2026-04-30 LEONARD KEITH R JR Director — 531 — —
2026-04-30 JOHNSON AMAL M Director — 531 — —
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
10,064.70
+20.51%
8,352.10
+17.24%
7,124.10
+14.49%
6,222.20
Operating Revenue
10,064.70
+20.51%
8,352.10
+17.24%
7,124.10
+14.49%
6,222.20
Cost Of Revenue
3,422.40
+25.92%
2,717.90
+13.50%
2,394.60
+18.18%
2,026.20
Reconciled Cost Of Revenue
3,422.40
+25.92%
2,717.90
+13.50%
2,394.60
+18.18%
2,026.20
Gross Profit
6,642.30
+17.89%
5,634.20
+19.13%
4,729.50
+12.71%
4,196.00
Operating Expense
3,696.80
+12.53%
3,285.30
+10.89%
2,962.70
+13.13%
2,618.90
Research And Development
1,311.80
+14.54%
1,145.30
+14.67%
998.80
+13.63%
879.00
Selling General And Administration
2,385.00
+11.45%
2,140.00
+8.97%
1,963.90
+12.87%
1,739.90
Total Expenses
7,119.20
+18.59%
6,003.20
+12.06%
5,357.30
+15.33%
4,645.10
Operating Income
2,945.50
+25.40%
2,348.90
+32.95%
1,766.80
+12.03%
1,577.10
Total Operating Income As Reported
2,945.50
+25.40%
2,348.90
+32.95%
1,766.80
+12.03%
1,577.10
EBITDA
3,622.60
+27.17%
2,848.60
+28.22%
2,221.60
+14.34%
1,942.90
Normalized EBITDA
3,622.60
+27.17%
2,848.60
+28.22%
2,221.60
+14.34%
1,942.90
Reconciled Depreciation
677.10
+35.50%
499.70
+9.87%
454.80
+24.33%
365.80
EBIT
2,945.50
+25.40%
2,348.90
+32.95%
1,766.80
+12.03%
1,577.10
Pretax Income
3,311.40
+23.85%
2,673.80
+36.49%
1,958.90
+21.91%
1,606.80
Net Non Operating Interest Income Expense
365.90
+12.62%
324.90
+69.13%
192.10
+546.80%
29.70
Net Interest Income
365.90
+12.62%
324.90
+69.13%
192.10
+546.80%
29.70
Interest Income Non Operating
365.90
+12.62%
324.90
+69.13%
192.10
+546.80%
29.70
Interest Income
365.90
+12.62%
324.90
+69.13%
192.10
+546.80%
29.70
Tax Provision
434.80
+29.29%
336.30
+137.50%
141.60
-46.04%
262.40
Tax Rate For Calcs
0.00
+3.97%
0.00
+75.00%
0.00
-55.83%
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
2,876.60
+23.06%
2,337.50
+28.62%
1,817.30
+35.18%
1,344.40
Net Income From Continuing Operation Net Minority Interest
2,856.00
+22.97%
2,322.60
+29.18%
1,798.00
+35.98%
1,322.30
Net Income From Continuing And Discontinued Operation
2,856.00
+22.97%
2,322.60
+29.18%
1,798.00
+35.98%
1,322.30
Net Income Continuous Operations
2,876.60
+23.06%
2,337.50
+28.62%
1,817.30
+35.18%
1,344.40
Minority Interests
-20.60
-38.26%
-14.90
+22.80%
-19.30
+12.67%
-22.10
Normalized Income
2,856.00
+22.97%
2,322.60
+29.18%
1,798.00
+35.98%
1,322.30
Net Income Common Stockholders
2,856.00
+22.97%
2,322.60
+29.18%
1,798.00
+35.98%
1,322.30
Diluted EPS
7.87
+22.59%
6.42
+27.63%
5.03
+37.81%
3.65
Basic EPS
8.00
+22.32%
6.54
+27.73%
5.12
+37.63%
3.72
Basic Average Shares
356.90
+0.48%
355.20
+1.14%
351.20
-1.27%
355.70
Diluted Average Shares
362.70
+0.19%
362.00
+1.29%
357.40
-1.27%
362.00
Diluted NI Availto Com Stockholders
2,856.00
+22.97%
2,322.60
+29.18%
1,798.00
+35.98%
1,322.30
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
20,458.70
+9.15%
18,743.20
+21.38%
15,441.50
+19.02%
12,974.00
Current Assets
9,779.50
+37.53%
7,111.00
-9.85%
7,888.00
+26.15%
6,253.00
Cash Cash Equivalents And Short Term Investments
5,934.90
+47.88%
4,013.30
-23.16%
5,223.20
+26.84%
4,117.90
Cash And Cash Equivalents
3,368.00
+66.12%
2,027.40
-26.28%
2,750.10
+73.92%
1,581.20
Cash Equivalents
2,853.10
+84.31%
1,548.00
-30.39%
2,223.90
+105.16%
1,084.00
Cash Financial
514.90
+7.41%
479.40
-8.89%
526.20
+5.83%
497.20
Other Short Term Investments
2,566.90
+29.26%
1,985.90
-19.70%
2,473.10
-2.51%
2,536.70
Receivables
1,628.20
+20.00%
1,356.80
+7.05%
1,267.50
+18.09%
1,073.30
Accounts Receivable
1,527.30
+24.64%
1,225.40
+8.42%
1,130.20
+19.97%
942.10
Gross Accounts Receivable
1,557.20
+23.97%
1,256.10
+8.54%
1,157.30
+19.99%
964.50
Allowance For Doubtful Accounts Receivable
-29.90
+2.61%
-30.70
-13.28%
-27.10
-20.98%
-22.40
Other Receivables
100.90
-23.21%
131.40
-4.30%
137.30
+4.65%
131.20
Inventory
1,840.00
+23.72%
1,487.20
+21.84%
1,220.60
+36.65%
893.20
Raw Materials
561.10
-0.50%
563.90
+24.02%
454.70
+18.75%
382.90
Work In Process
287.90
+39.96%
205.70
+28.64%
159.90
+0.00%
159.90
Finished Goods
991.00
+38.10%
717.60
+18.42%
606.00
+72.95%
350.40
Prepaid Assets
—
—
—
—
Other Current Assets
376.40
+48.36%
253.70
+43.58%
176.70
+4.80%
168.60
Total Non Current Assets
10,679.20
-8.19%
11,632.20
+54.00%
7,553.50
+12.39%
6,721.00
Net PPE
5,342.40
+14.97%
4,646.60
+31.35%
3,537.60
+49.00%
2,374.20
Gross PPE
7,618.90
+16.71%
6,527.90
+28.01%
5,099.60
+41.18%
3,612.10
Accumulated Depreciation
-2,276.50
-21.01%
-1,881.30
-20.44%
-1,562.00
-26.18%
-1,237.90
Properties
0.00
0.00
0.00
0.00
Land And Improvements
479.70
+0.69%
476.40
+4.18%
457.30
+17.68%
388.60
Buildings And Improvements
2,833.90
+90.67%
1,486.30
+48.32%
1,002.10
+15.65%
866.50
Machinery Furniture Equipment
1,570.60
+15.95%
1,354.50
+19.26%
1,135.80
+20.57%
942.00
Construction In Progress
638.10
-60.89%
1,631.60
+20.44%
1,354.70
+122.59%
608.60
Other Properties
2,096.60
+32.77%
1,579.10
+37.35%
1,149.70
+42.57%
806.40
Goodwill And Other Intangible Assets
381.40
+2.94%
370.50
-4.46%
387.80
-2.64%
398.30
Goodwill
370.30
+6.56%
347.50
-0.34%
348.70
+0.06%
348.50
Other Intangible Assets
11.10
-51.74%
23.00
-41.18%
39.10
-21.49%
49.80
Investments And Advances
3,099.20
-35.69%
4,819.10
+127.32%
2,120.00
-19.19%
2,623.60
Non Current Deferred Assets
1,018.60
-2.54%
1,045.10
+14.78%
910.50
+37.00%
664.60
Non Current Deferred Taxes Assets
1,018.60
-2.54%
1,045.10
+14.78%
910.50
+37.00%
664.60
Other Non Current Assets
837.60
+11.55%
750.90
+25.65%
597.60
-9.50%
660.30
Total Liabilities Net Minority Interest
2,517.00
+13.71%
2,213.60
+8.29%
2,044.20
+9.82%
1,861.40
Current Liabilities
2,006.20
+14.95%
1,745.30
+5.22%
1,658.70
+16.64%
1,422.10
Payables And Accrued Expenses
851.10
+14.87%
740.90
-4.55%
776.20
+24.55%
623.20
Payables
380.50
+9.40%
347.80
+15.89%
300.10
+23.45%
243.10
Accounts Payable
255.10
+31.90%
193.40
+2.49%
188.70
+28.37%
147.00
Current Accrued Expenses
470.60
+19.72%
393.10
-17.43%
476.10
+25.26%
380.10
Pensionand Other Post Retirement Benefit Plans Current
648.40
+21.06%
535.60
+22.73%
436.40
+8.67%
401.60
Total Tax Payable
125.40
-18.78%
154.40
+38.60%
111.40
+15.92%
96.10
Current Deferred Liabilities
506.70
+8.08%
468.80
+5.09%
446.10
+12.28%
397.30
Current Deferred Revenue
506.70
+8.08%
468.80
+5.09%
446.10
+12.28%
397.30
Total Non Current Liabilities Net Minority Interest
510.80
+9.08%
468.30
+21.48%
385.50
-12.25%
439.30
Long Term Debt And Capital Lease Obligation
—
—
—
—
Long Term Capital Lease Obligation
—
—
—
—
Tradeand Other Payables Non Current
193.60
-19.00%
239.00
+2.22%
233.80
-18.82%
288.00
Non Current Deferred Liabilities
91.40
+68.95%
54.10
+18.64%
45.60
+11.22%
41.00
Non Current Deferred Revenue
91.40
+68.95%
54.10
+18.64%
45.60
+11.22%
41.00
Other Non Current Liabilities
225.80
+28.88%
175.20
+65.13%
106.10
-3.81%
110.30
Stockholders Equity
17,824.00
+8.46%
16,433.70
+23.49%
13,307.60
+20.52%
11,041.90
Common Stock Equity
17,824.00
+8.46%
16,433.70
+23.49%
13,307.60
+20.52%
11,041.90
Capital Stock
0.40
+0.00%
0.40
+0.00%
0.40
+0.00%
0.40
Common Stock
0.40
+0.00%
0.40
+0.00%
0.40
+0.00%
0.40
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
355.10
-0.42%
356.60
+1.22%
352.30
+0.66%
350.00
Ordinary Shares Number
355.10
-0.42%
356.60
+1.22%
352.30
+0.66%
350.00
Additional Paid In Capital
10,768.50
+11.23%
9,681.30
+12.88%
8,576.40
+11.33%
7,703.90
Retained Earnings
7,011.80
+3.06%
6,803.30
+43.44%
4,743.00
+35.51%
3,500.10
Gains Losses Not Affecting Retained Earnings
43.30
+184.41%
-51.30
-320.49%
-12.20
+92.49%
-162.50
Minority Interest
117.70
+22.73%
95.90
+6.91%
89.70
+26.87%
70.70
Other Equity Adjustments
43.30
+184.41%
-51.30
-320.49%
-12.20
+92.49%
-162.50
Total Equity Gross Minority Interest
17,941.70
+8.54%
16,529.60
+23.38%
13,397.30
+20.56%
11,112.60
Total Capitalization
17,824.00
+8.46%
16,433.70
+23.49%
13,307.60
+20.52%
11,041.90
Working Capital
7,773.30
+44.87%
5,365.70
-13.86%
6,229.30
+28.95%
4,830.90
Invested Capital
17,824.00
+8.46%
16,433.70
+23.49%
13,307.60
+20.52%
11,041.90
Total Debt
—
—
—
—
Capital Lease Obligations
—
—
—
—
Net Tangible Assets
17,442.60
+8.59%
16,063.20
+24.33%
12,919.80
+21.39%
10,643.60
Tangible Book Value
17,442.60
+8.59%
16,063.20
+24.33%
12,919.80
+21.39%
10,643.60
Available For Sale Securities
3,099.20
-35.69%
4,819.10
+127.32%
2,120.00
—
Investmentin Financial Assets
3,099.20
-35.69%
4,819.10
+127.32%
2,120.00
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
3,030.50
+25.49%
2,415.00
+33.15%
1,813.80
+21.67%
1,490.80
Cash Flow From Continuing Operating Activities
3,030.50
+25.49%
2,415.00
+33.15%
1,813.80
+21.67%
1,490.80
Net Income From Continuing Operations
2,876.60
+23.06%
2,337.50
+28.62%
1,817.30
+35.18%
1,344.40
Depreciation Amortization Depletion
677.10
+35.50%
499.70
+9.87%
454.80
+24.33%
365.80
Depreciation
614.70
+38.04%
445.30
+10.88%
401.60
+18.82%
338.00
Amortization Cash Flow
62.40
+14.71%
54.40
+2.26%
53.20
+91.37%
27.80
Depreciation And Amortization
677.10
+35.50%
499.70
+9.87%
454.80
+24.33%
365.80
Amortization Of Intangibles
62.40
+14.71%
54.40
+2.26%
53.20
+91.37%
27.80
Other Non Cash Items
—
37.70
+14.24%
33.00
+24.06%
26.60
Stock Based Compensation
788.20
+16.46%
676.80
+14.17%
592.80
+15.51%
513.20
Deferred Tax
19.10
+114.12%
-135.30
+51.82%
-280.80
-51.54%
-185.30
Deferred Income Tax
19.10
+114.12%
-135.30
+51.82%
-280.80
-51.54%
-185.30
Operating Gains Losses
-58.20
-31.08%
-44.40
-708.22%
7.30
-83.85%
45.20
Gain Loss On Investment Securities
-57.20
-32.10%
-43.30
-693.15%
7.30
-85.10%
49.00
Change In Working Capital
-1,272.30
-38.40%
-919.30
-18.22%
-777.60
-25.60%
-619.10
Change In Receivables
-301.70
-214.60%
-95.90
+48.52%
-186.30
-16.95%
-159.30
Changes In Account Receivables
-301.70
-214.60%
-95.90
+48.52%
-186.30
-16.95%
-159.30
Change In Inventory
-1,063.40
-28.12%
-830.00
-16.49%
-712.50
-30.35%
-546.60
Change In Prepaid Assets
-187.10
+19.28%
-231.80
-1057.85%
24.20
+118.73%
-129.20
Change In Payables And Accrued Expense
57.90
+14575.00%
-0.40
-100.96%
41.70
+95.77%
21.30
Change In Payable
57.90
+14575.00%
-0.40
-100.96%
41.70
+95.77%
21.30
Change In Account Payable
57.90
+14575.00%
-0.40
-100.96%
41.70
+95.77%
21.30
Change In Other Working Capital
187.90
+43.98%
130.50
+47.96%
88.20
+20.82%
73.00
Change In Other Current Liabilities
34.10
-68.51%
108.30
+429.18%
-32.90
-127.03%
121.70
Investing Cash Flow
665.80
+120.34%
-3,272.80
-808.86%
-360.10
-126.27%
1,370.80
Cash Flow From Continuing Investing Activities
665.80
+120.34%
-3,272.80
-808.86%
-360.10
-126.27%
1,370.80
Net PPE Purchase And Sale
-539.80
+51.42%
-1,111.20
-4.42%
-1,064.20
-99.89%
-532.40
Purchase Of PPE
—
—
—
—
Capital Expenditure
-539.80
+51.42%
-1,111.20
-4.42%
-1,064.20
-99.89%
-532.40
Net Investment Purchase And Sale
1,219.50
+156.44%
-2,160.60
-403.03%
713.00
-62.79%
1,916.00
Purchase Of Investment
-1,215.90
+76.34%
-5,139.60
-132.84%
-2,207.40
-57.73%
-1,399.50
Sale Of Investment
2,435.40
-18.25%
2,979.00
+2.01%
2,920.40
-11.92%
3,315.50
Net Business Purchase And Sale
-13.90
-1290.00%
-1.00
+88.76%
-8.90
+30.47%
-12.80
Purchase Of Business
-13.90
-1290.00%
-1.00
+88.76%
-8.90
+30.47%
-12.80
Gain Loss On Sale Of Business
-1.00
+9.09%
-1.10
0.00
+100.00%
-3.80
Financing Cash Flow
-2,364.10
-1666.67%
150.90
+152.47%
-287.60
+88.82%
-2,572.30
Cash Flow From Continuing Financing Activities
-2,364.10
-1666.67%
150.90
+152.47%
-287.60
+88.82%
-2,572.30
Net Common Stock Issuance
-2,295.30
0.00
+100.00%
-416.30
+84.03%
-2,607.40
Common Stock Payments
-2,295.30
0.00
+100.00%
-416.30
+84.03%
-2,607.40
Repurchase Of Capital Stock
-2,295.30
0.00
+100.00%
-416.30
+84.03%
-2,607.40
Proceeds From Stock Option Exercised
350.30
-18.42%
429.40
+44.92%
296.30
+26.73%
233.80
Net Other Financing Charges
-419.10
-50.48%
-278.50
-66.17%
-167.60
+15.65%
-198.70
Changes In Cash
1,332.20
+288.46%
-706.90
-160.62%
1,166.10
+303.08%
289.30
Effect Of Exchange Rate Changes
12.80
+1700.00%
-0.80
-124.24%
3.30
-38.89%
5.40
Beginning Cash Position
2,062.40
-25.55%
2,770.10
+73.06%
1,600.70
+22.57%
1,306.00
End Cash Position
3,407.40
+65.22%
2,062.40
-25.55%
2,770.10
+73.06%
1,600.70
Free Cash Flow
2,490.70
+91.03%
1,303.80
+73.93%
749.60
-21.79%
958.40
Income Tax Paid Supplemental Data
537.90
+15.31%
466.50
+4.18%
447.80
+0.81%
444.20
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category